Symplicity HTN-2 with Dr Murray Esler
This feature requires the newest version of Flash. You can download it here.


Dr Murray Esler (IDI Heart and Diabetes Institute, Melbourne, Australia) discusses Symplicity HTN-2: International, Multicenter, Prospective, Randomized, Controlled Trial of Endovascular Selective Renal Sympathetic Denervation for the Treatment of Hypertension with Dr Gabriel Steg.

Filmed during AHA 2010 in Chicago, IL on November 14.

See:
A revolutionary road for resistant hypertension? Renal denervation in Symplicity HTN-2